Assure Holdings Corp. Announces Exploration of Strategic Alternatives
DENVER, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative
neuromonitoring (“IONM”) and remote neurology services, today announced that its Board of Directors has initiated a process to explore strategic alternatives. In consultation with
financial and legal advisors, the comprehensive strategic review process will begin immediately and will evaluate a broad range of options to maximize shareholder value.
As part of this review process, Assure will explore potential strategic alternatives that may include, but are not limited to, an acquisition, merger, business combination, sale of assets or other strategic or financial transaction. There can be no assurance that this review process will result in pursuing a transaction or that any transaction, if pursued, will be completed.
The Company has not set a timetable for completion of this review process and does not intend to comment further unless or until the Board of Directors has approved a definitive course of action, the review process is concluded without action, or it is determined that other disclosure is appropriate or required by law.
Assure Holdings Corp. has retained Joseph Gunnar & Co. LLC as its exclusive financial advisor to advise in the review process.
Lesen Sie auch
About Assure Holdings
Assure Holdings Corp. is a best-in-class provider of outsourced intraoperative neuromonitoring and remote neurology services. The Company delivers a turnkey suite of clinical and operational
services to support surgeons and medical facilities during invasive procedures that place the nervous system at risk including neurosurgery, spine, cardiovascular, orthopedic and ear, nose and
throat surgeries. Assure employs highly trained technologists that provide a direct point of contact in the operating room. Physicians employed through Assure subsidiaries simultaneously monitor
the functional integrity of patients’ neural structures throughout the procedure communicating in real-time with the surgeon and technologist. Accredited by The Joint Commission, Assure’s mission
is to provide exceptional surgical care and a positive patient experience. For more information, visit the company’s website at www.assureneuromonitoring.com